Coronavirus Disease 2019 (COVID-19) is a pandemic disease that increased the burden on health-care system. In the Kingdom of Saudi Arabia, 74,795 cases have been reported until 26 May 2020 and the number of cases is rapidly increasing. The mortality rate of COVID-19 worldwide is 6.37%. Here we report three cases of acute kidney injury (AKI) secondary to pneumonia of severe COVID-19; they were treated with automated peritoneal dialysis (PD) with full recovery. To the best of our knowledge, few reports in the literature have discussed the use of PD in AKI secondary to COVID-19.
GuanW-JNiZ-YHuY, et al.Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med2020; 382: 1708–1720.
2.
BellomoRMansfieldDRumbleS, et al.A comparison of conventional dialytic therapy and acute continuous hemodiafiltration in the management of acute renal failure. Ren Fail1993; 15: 595–602.
3.
CullisBAbdelraheemMAbrahamsG, et al.ISPD guidelines/recommendations. Peritoneal dialysis in AKI. Perit Dial Int2014; 34(5): 494–517.
4.
SrivatanaVAggarwalVFinkelsteinFO, et al.Peritoneal dialysis for acute kidney injury treatment in the United States: brought to you by the COVID-19 pandemic. Kidney360. Epub ahead of print 24 April 2020. DOI: 10.34067/KID.0002152020.
5.
ZemelDImholtzALDe WaartDR, et al.Appearance of tumor necrosis factor-α and soluble TNF-receptors I and II in peritoneal effluent of CAPD. Kidney Int1994; 46: 1422–1430.
6.
FincherMECampbellHTSklarAH, et al.Atrial natriuretic peptide (ANP) is removed by peritoneal dialysis in humans. Adv Perit Dial1989; 5: 16–19.
